Evidence map›Paper›PMID 29880492›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

VEGF (Vascular Endothelial Growth Factor) Induces NRP1 (Neuropilin-1) Cleavage via ADAMs (a Disintegrin and Metalloproteinase) 9 and 10 to Generate Novel Carboxy-Terminal NRP1 Fragments That Regulate Angiogenic Signaling.

Vedanta Mehta, Laura Fields, Ian M Evans, Maiko Yamaji, Caroline Pellet-Many, Timothy Jones, Marwa Mahmoud, Ian Zachary

Open access · greenAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Article
  3. Neuropilin-1: A Multifaceted Target for Cancer Therapy.Current oncology (Toronto, Ont.) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. VEGF controls microglial phagocytic response to amyloid-β.Frontiers in cellular neuroscience · 2023
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Fetal Blood Flow and Genetic Mutations in Conotruncal Congenital Heart Disease.Journal of cardiovascular development and disease · 2021
    Review
  19. Review
  20. Cerebrovascular development: mechanisms and experimental approaches.Cellular and molecular life sciences : CMLS · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Vedanta MehtaFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Laura FieldsFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Ian M EvansFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Maiko YamajiFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Caroline Pellet-ManyFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Timothy JonesFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Marwa MahmoudFrom the Centre for Cardiovascular Biology and Medicine, Division of Medicine, The Rayne Building, University College London, United Kingdom.
Ian Zachary
Gravesham Community Hospital · GB

Funding

British Heart Foundation PG/12/65/29840British Heart Foundation PG/16/84/32464British Heart Foundation PG/17/87/33400British Heart Foundation RG/06/003British Heart Foundation RG/11/11/29050
6 · The paper itself

Abstract

Objective- NRP1(neuropilin-1) acts as a coreceptor for VEGF (vascular endothelial growth factor) with an essential role in angiogenesis. Recent findings suggest that posttranslational proteolytic cleavage of VEGF receptors may be an important mechanism for regulating angiogenesis, but the role of NRP1 proteolysis and the NRP1 species generated by cleavage in endothelial cells is not known. Here, we characterize NRP1 proteolytic cleavage in endothelial cells, determine the mechanism, and investigate the role of NRP1 cleavage in regulation of endothelial cell function. Approach and Results- NRP1 species comprising the carboxy (C)-terminal and transmembrane NRP1 domains but lacking the ligand-binding A and B regions are constitutively expressed in endothelial cells. Generation of these C-terminal domain NRP1 proteins is upregulated by phorbol ester and Ca

Indexed as

ADAMTS9 ProteinADAMTS ProteinsAngiogenesis Inducing AgentsAnimalsCell MovementCells, CulturedCoculture TechniquesHumansHuman Umbilical Vein Endothelial CellsMiceNeovascularization, PhysiologicNeuropilin-1Peptide FragmentsPhosphorylationProtein BindingProtein Interaction Domains and MotifsADAMTS10 protein, humanADAMTS9 ProteinADAMTS9 protein, humanADAMTS ProteinsAngiogenesis Inducing AgentsKDR protein, humanNeuropilin-1NRP1 protein, humanPeptide FragmentsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2VEGFA protein, humancytokinesendothelial cellsphosphorylationproteolysissignal transduction

Identifiers

PMID29880492
PMCPMC6092111
OpenAlexW2806940382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.